May 24, 2016 / 7:51 AM / a month ago

BRIEF-Santhera FY Net Revenues Down At EUR 27.9 Million

Jan 27 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* SANTHERA REPORTS NET REVENUES 2019 AND HIGHLIGHTS PIPELINE PROGRESS

* NET REVENUES CHF 27.9 MILLION IN 2019

* 2019 GROSS INCOME OF CHF 49.3 MILLION FROM RAXONE OUT-LICENSING AGREEMENT

* IN 2019, SANTHERA REPORTED NET REVENUES OF CHF 27.9 MILLION (2018: CHF 31.7 MILLION)

* AS OF DECEMBER 31, 2019, FREELY AVAILABLE LIQUID FUNDS (CASH AND CASH EQUIVALENTS) AMOUNTED TO CHF 31.4 MILLION (AUGUST 31, 2019: CHF 43.7 MILLION) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below